Results 41 to 50 of about 44,720 (221)

Mortality rate and prognostic factors for poor outcome in HIV-infected Bulgarian patients with Pneumocystis pneumonia over a 3-year period

Problems of Infectious and Parasitic Diseases, 2020
Background: In spite of the use of combination antiretroviral therapy and specific prophylaxis, Pneumocystis pneumonia remains one of the most common AIDS-defining disease with high mortality rate.
Nina Yancheva, Dimitar Strashimirov, Maria Nikolova, Ivailo Alexiev, Aleksandra Ivanova, Nina Tsvetkova   +5 more
doaj   +1 more source

Pneumocystis jirovecii pneumonia induced by low-dose methotrexate in a patient with chronic urticaria [PDF]

Anais Brasileiros de Dermatologia, 2017
Methotrexate has immunosuppressive effects and is administered for refractory chronic urticaria. We present a case of Pneumocystis jirovecii pneumonia in a patient with refractory chronic urticaria managed by low-dose weekly methotrexate treatment (total
Sheng-Huei Wang, Shih-En Tang, Yu-Huei Li, Kuang-Yu Wei, Chan-Yuan Chang   +4 more
doaj   +1 more source

Development and Evaluation of Rapid and Accurate CRISPR/Cas13-Based RNA Diagnostics for Pneumocystis jirovecii Pneumonia

Frontiers in Cellular and Infection Microbiology, 2022
BackgroundPneumocystis jirovecii can result in a serious pulmonary infection, Pneumocystis jirovecii pneumonia, in immunocompetent hosts. The diagnosis of Pneumocystis jirovecii pneumonia has long been a major clinical concern, and there are limitations ...
Yangqing Zhan, Xiaoqing Gao, Shaoqiang Li, Yeqi Si, Yuanxiang Li, Xu Han, Wenjun Sun, Zhengtu Li, Feng Ye   +8 more
doaj   +1 more source

Detection of DNA in samples from patients suspected of bacterial pneumonia- a case-control study [PDF]

, 2002
Background Pneumocystis jiroveci (formerly known as P. carinii f.sp. hominis) is an opportunistic fungus that causes Pneumocystis pneumonia (PCP) in immunocompromised individuals. Pneumocystis jiroveci can be detected by polymerase chain reaction (PCR).
JR Stringer, J Helweg-Larsen, J Helweg-Larsen, AE Wakefield, JA Hunter, SN Huang, P Roux, SH Yale, KA Sepkowitz, SM Arend, A Sing, M Rabodonirina, SL Peglow, SL Vargas, W Chen, SL Vargas, SE Peters, A Dumoulin, G Nevez, M Olsson, T Takahashi, A Sing, E Visconti, HS Oz, OP Settnes, MJ Fine, HH Larsen   +26 more
core   +1 more source

Pharmacokinetics of dolutegravir, tenofovir and lamivudine during venous–venous extracorporeal membrane oxygenation (VV‐ECMO): A case report

British Journal of Clinical Pharmacology, EarlyView.
While providing potentially life‐saving cardiorespiratory support for critically ill patients, extracorporeal membrane oxygenation (ECMO) may detrimentally affect pharmacokinetic (PK) performance and concurrent drug efficacy and safety. We describe a patient with Pneumocystis jirovecii pneumonia (PJP) in the context of acquired immunodeficiency ...
Tom C. Zwart, Emiel Leegwater, Thomas H. Ottens, Emile F. Schippers, Erik B. Wilms, David M. Burger, Cees van Nieuwkoop, Liesbeth B. E. Bosma   +7 more
wiley   +1 more source

Limited asymptomatic carriage of Pneumocystis jiroveci in human immunodeficiency virus-infected patients [PDF]

, 2003
Forty-seven bronchoalveolar lavage fluid samples from 16 human immunodeficiency virus (HIV)-infected patients were used to test the latency model of Pneumocystis infection in the human host.
Ambrose, HE, Denis, CM, Lindley, AR, Miller, RF, Wakefield, AE   +4 more
core  

Efficacy of upadacitinib induction for pediatric inflammatory bowel disease

JPGN Reports, EarlyView.
Abstract Objectives Upadacitinib, a second‐generation Janus kinase (JAK) inhibitor, is approved for moderate to severe Crohn's disease (CD) and ulcerative colitis (UC) in adults. Its efficacy in pediatric patients remains unclear, though early reports suggest benefits in refractory inflammatory bowel disease (IBD).
Evan Greenhall, Nina Gautam, Paula Prieto‐Jimenez, Elizabeth Hilow, Ashish Patel, Brad Pasternak   +5 more
wiley   +1 more source

Ventilator-associated Pneumonia After Elective Cardiac Surgery Caused by Pneumocystis Jirovecii [PDF]

, 2014
Ventilator-associated pneumonia is a severe complication among patients undergoing cardiac surgery. Although hospital-acquired bacterial pathogens, often multidrug resistant, are the most frequent cause, non-bacterial atypical and opportunistic agents ...
Cifuentes, M, Miller, RF, Silva, F, Tobar, E, Vargas, SL, Zamorano, A   +5 more
core  

Autoimmune inflammatory disorders, systemic corticosteroids and pneumocystis pneumonia: A strategy for prevention [PDF]

, 2004
Background Pneumocystis pneumonia (PCP) is an increasing problem amongst patients on immunosuppression with autoimmune inflammatory disorders (AID). The disease presents acutely and its diagnosis requires bronchoalveolar lavage in most cases.
Evin Sowden, Andrew J Carmichael, C Chagas, O Goetz, SE Follansbee, JR Stringer, JA Kovacs, AE Wakefield, CB Beard, J Helweg-Larsen, ES Manoloff, SL Vargas, AE Wakefield, L Casanova-Cardiel, S Safrin, JG Gerrard, F Roblot, R Nuesch, SH Yale, SM Arend, NG Mansharamani, MS Bartlett, W Koldingsnes, B Godeau, P Cregan, M Orholm, DB Hellmann, RT Davey Jr, MM Ward, H Bachelez, TL Lamagni, FP Ognibene, SP Raychaudhuri, AJ Porges, SD Hearing, B Godeau, EW Walton, GS Hoffman, A Kadoya, J Phair, G Nevez, DS Stein, WT Hughes, WT Hughes, H Masur   +44 more
core   +2 more sources

Upper Airway Obstruction due to Kaposi Sarcoma—Presenting Sign of HIV: Case Report and Review

The Laryngoscope, EarlyView.
This study presents a case of undiagnosed HIV presenting with Kaposi sarcoma (KS) of the head and neck with acute upper airway obstruction (UAO) and provides an updated scoping literature review to examine the patient characteristics, lesion characteristics, interventions, and outcomes of KS cases with UAO from the pharynx, larynx, and/or trachea.
Zachary A. Wykoff, Logan F. McColl, Robert A. Baiocchi, Matthew O. Old   +3 more
wiley   +1 more source